Rx Pharmaceuticals

A separate unit of the company specialises in full-cycle drug development, from molecule synthesis to the development of a finished dosage form.

Our experts are engaged in the testing and application of technologies in industrial production, as well as in the organisation of pre-clinical and clinical research.

The company's scientific, technological and human resources are focused on the manufacture of products that meet the strictest international quality standards.
An innovative formula consisting of peptides aimed at restoring the functional state of brain neurones that have suffered damage as a result of the onset of a neurodegenerative disease. This action is explained by the prevention of the reduction of dendritic spines of neurons.
AMRITEX Neuro®
-
preclinical

A peptide formula that shows an extreme efficacy in slowing down the development of retinitis pigmentosa - an incururable genetic disorder that leads to total blindness. The formulation protects the retina cells from damage by stimulating the protein synthesis in the target cells. Effective in cases of several other macular degenerations.
AMRITEX Retina®
-
preclinical

Preclinical
Testing of drug in non-human subjects to gather efficacy, toxicity and pharmacokinetic information, particularly oral bioavailability and half-life of the drug
Phase 1
Dose-ranging on healthy volunteers for safety. Designed to test the safety, side effects, best dose, and formulation method for the drug.
Phase 2
Testing of drug on patients to assess efficacy and side effects. Performed on larger groups (50–300) and are designed to assess how well the drug works
Phase 3
Testing of drug on patients to assess efficacy, effectiveness and safety. Studies are randomized controlled multicenter trials on large patient groups and are aimed at being the definitive assessment of how effective the drug is.
Meet our team
Get acquainted and follow the journey of the people behind the development of this revolutionary technology
R&D sites
Our company boasts a mixture of in house research as well as cooperation with major world laborotries